
Khatol S. Shahnan Shah
Examiner (ID: 10988, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 690 |
| Issued Applications | 340 |
| Pending Applications | 103 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17793505
[patent_doc_number] => 20220252597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => New Core/Shell Materials of Nanowire/Graphene on Low-Cost RFID Tags for Rapidly Sensing Live Cell Metabolites at Single-Cell Sensitivity
[patent_app_type] => utility
[patent_app_number] => 17/670408
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670408 | New Core/Shell Materials of Nanowire/Graphene on Low-Cost RFID Tags for Rapidly Sensing Live Cell Metabolites at Single-Cell Sensitivity | Feb 10, 2022 | Abandoned |
Array
(
[id] => 19097791
[patent_doc_number] => 20240117019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 18/264733
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264733 | HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS | Feb 6, 2022 | Pending |
Array
(
[id] => 17609903
[patent_doc_number] => 20220152182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/588425
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588425 | VACCINE | Jan 30, 2022 | Pending |
Array
(
[id] => 17609858
[patent_doc_number] => 20220152137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => FEED SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 17/588910
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588910 | Feed supplement | Jan 30, 2022 | Issued |
Array
(
[id] => 20262953
[patent_doc_number] => 12433921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Bacteria
[patent_app_type] => utility
[patent_app_number] => 17/579006
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8690
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579006 | Bacteria | Jan 18, 2022 | Issued |
Array
(
[id] => 18483615
[patent_doc_number] => 20230210916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Bacteriocin Production, Compositions and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 17/573193
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573193 | Bacteriocin Production, Compositions and Methods of Use | Jan 10, 2022 | Abandoned |
Array
(
[id] => 17564423
[patent_doc_number] => 20220128572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/567623
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/567623 | IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY | Jan 2, 2022 | Abandoned |
Array
(
[id] => 17685865
[patent_doc_number] => 20220193157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/557939
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557939 | None | Dec 20, 2021 | Issued |
Array
(
[id] => 17657463
[patent_doc_number] => 20220177928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS
[patent_app_type] => utility
[patent_app_number] => 17/555867
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555867 | PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS | Dec 19, 2021 | Abandoned |
Array
(
[id] => 18449512
[patent_doc_number] => 20230190788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications
[patent_app_type] => utility
[patent_app_number] => 17/551882
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551882 | Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications | Dec 14, 2021 | Issued |
Array
(
[id] => 17762672
[patent_doc_number] => 20220236284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Therapeutically Triggering an Innate Immune Response in a Target Tissue
[patent_app_type] => utility
[patent_app_number] => 17/542820
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542820 | Therapeutically Triggering an Innate Immune Response in a Target Tissue | Dec 5, 2021 | Pending |
Array
(
[id] => 17627257
[patent_doc_number] => 20220162272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COMPOSITIONS AND METHODS OF DETERMINING A LEVEL OF INFECTION IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 17/541365
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541365 | COMPOSITIONS AND METHODS OF DETERMINING A LEVEL OF INFECTION IN A SUBJECT | Dec 2, 2021 | Abandoned |
Array
(
[id] => 17685922
[patent_doc_number] => 20220193214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Triple Vaccine for Diseases Caused by Salmonella typhimurium, Riemerella anatipestifer and Escherichia coli
[patent_app_type] => utility
[patent_app_number] => 17/532217
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532217 | Triple vaccine for diseases caused by | Nov 21, 2021 | Issued |
Array
(
[id] => 17561752
[patent_doc_number] => 20220125901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/527488
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527488 | TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA | Nov 15, 2021 | Abandoned |
Array
(
[id] => 20403062
[patent_doc_number] => 12493035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Cellular vamp cleavage assay
[patent_app_type] => utility
[patent_app_number] => 17/451900
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 24
[patent_no_of_words] => 13256
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/451900 | Cellular vamp cleavage assay | Oct 21, 2021 | Issued |
Array
(
[id] => 17482150
[patent_doc_number] => 20220089654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/472936
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472936 | Mutant transporters for bacterial uptake of terephthalic acid | Sep 12, 2021 | Issued |
Array
(
[id] => 18860304
[patent_doc_number] => 20230414738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => HAEMOPHILUS INFLUENZAE VACCINE AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/043241
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043241 | HAEMOPHILUS INFLUENZAE VACCINE AND METHODS OF USE | Sep 9, 2021 | Pending |
Array
(
[id] => 17155026
[patent_doc_number] => 20210316077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => BOTULINUM TOXIN PREFILLED CONTAINER
[patent_app_type] => utility
[patent_app_number] => 17/356300
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356300 | Botulinum toxin prefilled container | Jun 22, 2021 | Issued |
Array
(
[id] => 18737998
[patent_doc_number] => 20230346902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Shigella-Tetravalent (Shigella4V) Bioconjugate
[patent_app_type] => utility
[patent_app_number] => 18/001551
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001551
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001551 | Shigella-Tetravalent (Shigella4V) Bioconjugate | Jun 16, 2021 | Pending |
Array
(
[id] => 17343521
[patent_doc_number] => 20220009852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => BACILLUS SUBTILIS BS40-4 STRAIN AND METHOD FOR COMPOSTING ORGANIC WASTES BY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/349960
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349960 | BACILLUS SUBTILIS BS40-4 STRAIN AND METHOD FOR COMPOSTING ORGANIC WASTES BY USING THE SAME | Jun 16, 2021 | Abandoned |